Showing results (1-10 of 48) with videos related to
Sort By:
Pageof 5
Methods in Molecular Medicine|December 19, 2007
Artificial pancreas to treat type 1 diabetes mellitusRiccardo Calafiore, Giuseppe BastaCurrent Diabetes Reports|August 10, 2011
Immunoisolation of pancreatic islet grafts with no recipient's immunosuppression: actual and future perspectivesGiuseppe Basta, Riccardo CalafioreAdvanced Drug Delivery Reviews|November 5, 2013
Clinical application of microencapsulated islets: actual prospectives on progress and challengesRiccardo Calafiore, Giuseppe BastaAmerican Journal of Stem Cells|May 15, 2015
Stem cells for the cell and molecular therapy of type 1 diabetes mellitus (T1D): the gap between dream and realityRiccardo Calafiore, Giuseppe BastaTissue Engineering. Part A|July 2, 2009
In vitro-cultured human islet cell monolayers: stemness markers and insulin recovery upon streptozotocin exposurePia Montanucci, Giuseppe Basta, Riccardo CalafioreCurrent Opinion in Organ Transplantation|February 21, 2014
Stem cells for pancreatic β-cell replacement in diabetes mellitus: actual perspectivesRiccardo Calafiore, Pia Montanucci, Giuseppe BastaMethods in Molecular Biology (Clifton, N.J.)|October 15, 2016
Microencapsulation of Islets for the Treatment of Type 1 Diabetes Mellitus (T1D)Riccardo Calafiore, Giuseppe Basta, Pia MontanucciJournal of Diabetes Investigation|July 24, 2020
Microencapsulation of cells and molecular therapy of type 1 diabetes mellitus: The actual state and future perspectives between promise and progressGiuseppe Basta, Pia Montanucci, Riccardo CalafioreRecenti Progressi in Medicina|January 27, 2007
[New frontiers for the therapy of insulin-dependent diabetes mellitus]Riccardo Calafiore, Giuseppe Basta, Giovanni Luca, et al.Frontiers in Immunology|December 6, 2023
GLP-1 RAs and SGLT2i: two antidiabetic agents associated with immune and inflammation modulatory properties through the common AMPK pathwayAlessio Mazzieri, Giuseppe Basta, Riccardo Calafiore, et al.Pageof 5